The change to open listing on the NL Prescription Drug Program reduces the administrative burden of prescribers by eliminating the special authorization process that had been in place.
Government is expanding prescription coverage for long-acting muscarinic antagonist (LAMAs) inhalers, used in the treatment of Chronic Obstructive Pulmonary Disease. The change to open listing on the NL Prescription Drug Program reduces the administrative burden of prescribers by eliminating the special authorization process that had been in place. This will ensure NLPDP beneficiaries have timely access to these inhalers for the treatment of their COPD.
UPDATE: Route 430 re-opened near Mill Brook
One man was injured at a workplace accident in Corner Brook yesterday
No injuries in a hit and run in Stephenville yesterday afternoon
The annual Corner Brook Bay of Islands Pride Parade is tomorrow with a celebration at the Majestic Lawn
BOISAR uses new drone to pinpoint the location of lost hikers near Corner Brook
